Medicare Enrolled

Dr. Mary Oberst, M.D.

Cardiovascular Disease · Vero Beach, FL
Practice pattern: Cardiac & Cardiac— Practice combining cardiac and cardiac services
Low-engagement
3450 11TH CT STE 102, Vero Beach, FL 32960
7727788687
In practice since 2005 (20 years)
NPI: 1174510168 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oberst from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oberst? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Oberst

Dr. Mary Oberst is a cardiovascular disease in Vero Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Oberst performed 1,555 Medicare services across 1,261 unique beneficiaries.

Between the years covered by Open Payments, Dr. Oberst received a total of $6,523 from 32 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Oberst is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 1,555 Medicare services$ $6,523 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,555
Medicare services
Bottom 38% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,261
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Echocardiogram, transthoracic289$53$473
Heart muscle strain imaging228$9$29
Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services161$20$77
Hospital follow-up visit, moderate complexity124$65$173
Hospital follow-up visit, high complexity104$99$242
Initial hospital admission, moderate complexity103$105$1,617
Office visit, established patient (20-29 min)85$53$170
Heart rhythm review and interpretation of continous external ekg over 8-15 days68$21$62
New patient office visit (45-59 min)68$99$322
Ct scan of blood vessels and grafts of heart with contrast61$91$871
Office visit, established patient (30-39 min)32$78$205
EKG interpretation and report29$7$54
Ultrasound of heart, follow-up27$20$224
Ultrasound of heart with color-depicted blood flow, rate and valve function20$2$58
New patient office visit (30-44 min)20$63$216
New patient office visit, complex (60-74 min)20$138$403
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes19$67$1,408
Remote patient monitoring management, 20 min/month18$38$147
Mri scan of heart before and after contrast17$95$944
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician17$17$53
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician17$11$53
Ultrasound of heart blood flow, valves and chambers, follow-up15$6$62
Office visit, established patient, complex (40-54 min)13$119$240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.8% high complexity
23.6% medium
55.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,523
Total received (2018-2024)
Avg $932/year across 7 years
Top 33% in FL for cardiovascular disease
32
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,523 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$295
2023
$1,172
2022
$1,180
2021
$443
2020
$489
2019
$1,686
2018
$1,259

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,183
Amgen Inc.
$1,110
Janssen Pharmaceuticals, Inc
$728
Abbott Laboratories
$443
PFIZER INC.
$308
Boston Scientific Corporation
$294
Regeneron Healthcare Solutions, Inc.
$227
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$210
E.R. Squibb & Sons, L.L.C.
$206
Edwards Lifesciences Corporation
$193
SANOFI-AVENTIS U.S. LLC
$182
Amarin Pharma Inc.
$174
ShockWave Medical, Inc
$148
CVRx, Inc.
$139
W. L. Gore & Associates, Inc.
$130
Lundbeck LLC
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
AstraZeneca Pharmaceuticals LP
$86
AtriCure, Inc.
$81
Actelion Pharmaceuticals US, Inc.
$79
Medtronic Vascular, Inc.
$69
Gilead Sciences, Inc.
$48
Esperion Therapeutics, Inc.
$45
Intuitive Surgical, Inc.
$44
Lantheus Medical Imaging, Inc.
$28
Novo Nordisk Inc
$22
iRhythm Technologies, Inc.
$19
BAXTER HEALTHCARE
$16
ARBOR PHARMACEUTICALS, INC.
$16
Astellas Pharma US Inc
$16
Chiesi USA, Inc.
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Top 3 companies account for 46.3% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · ANDEXXA · BRILINTA · Barostim Neo System · Bidil · CAMZYOS · CHANTIX · COSEAL · Corlanor · Da Vinci Surgical System · Definity · ELIQUIS · ENTRESTO · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · GORE CARDIOFORM Septal Occluder · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LOKELMA · LifeVest · MITRACLIP · MULTAQ · Models · NEXLETOL · NORTHERA · OPSUMIT · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Saxenda · UPTRAVI · VYNDAQEL · Vascepa · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $419 per 100 Medicare services performed
Looking for a cardiovascular disease in Vero Beach?
Compare cardiovascular diseases in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
43
Per 100K population
26.2
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Oberst is a cardiac & cardiac specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Oberst experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Oberst performed 289 echocardiogram, transthoracic services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oberst receive payments from pharmaceutical companies?
Yes. Dr. Oberst received a total of $6,523 from 32 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oberst's costs compare to other cardiovascular diseases in Vero Beach?
Dr. Oberst's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oberst) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →